LifeMD (LFMD)

LifeMD’s continuing operations are organised around telehealth. The platform supports services across areas such as primary care, men’s health, dermatology, weight management, and other recurring treatment categories where virtual engagement can reduce friction for patients. The company uses its own commercial pharmacy capabilities alongside a wider nationwide pharmacy network, allowing it to coordinate prescribing, fulfilment, and patient support more directly than many asset-light telehealth providers.

A key feature of LifeMD’s business is its vertically integrated approach. It combines consumer acquisition, clinical workflows, patient care centre operations, pharmacy access, and AI-enabled technology intended to improve efficiency and retention. This structure gives the company more control over the patient experience, from initial marketing contact through consultation, prescription management, and follow-up care.

For investors, LFMD offers exposure to the evolving market for digital healthcare and consumer-driven medical services. Its performance depends on patient acquisition costs, subscription and repeat-use behaviour, provider network quality, pharmacy execution, regulatory compliance, and the ability to expand care categories while maintaining clinical standards. The company sits at the intersection of telemedicine, online pharmacy, and personalised consumer healthcare.